Growth Metrics

Soleno Therapeutics (SLNO) EPS (Basic) (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29.41%
Dec 31, 2025 73.47%
Sep 30, 2025 644.44%
Jun 30, 2025 90.53%
Mar 31, 2025 26.92%
Dec 31, 2024 28.96%
Sep 30, 2024 -221.05%
Jun 30, 2024 3.39%
Mar 31, 2024 -303.45%
Dec 31, 2023 130.53%
Sep 30, 2023 -17.28%
Jun 30, 2023 7.95%
Mar 31, 2023 -57.14%
Dec 31, 2022 13.85%
Sep 30, 2022 9.72%
Jun 30, 2022 32.71%
Mar 31, 2022 -101.89%
Dec 31, 2021 65.36%
Sep 30, 2021 -992.86%
Jun 30, 2021 -27.27%
Mar 31, 2021 -1,000.00%
Dec 31, 2020 90.91%
Sep 30, 2020 31.25%
Jun 30, 2020 -23.08%
Mar 31, 2020 66.67%
Dec 31, 2019 -1,400.00%
Sep 30, 2019 109.68%
Jun 30, 2019 -40.91%
Mar 31, 2019 -833.33%
Dec 31, 2018 123.08%
Sep 30, 2018 62.86%
Jun 30, 2018 -84.21%
Mar 31, 2018 48.65%
Dec 31, 2017 -42.31%
Sep 30, 2017 38.10%
Jun 30, 2017 -5.00%
Mar 31, 2017 88.02%
Dec 31, 2016 -283.91%
Sep 30, 2016 -278.26%
Jun 30, 2016 99.90%
Mar 31, 2016 -244,344.44%
Dec 31, 2015 72.73%
Sep 30, 2015 -232.00%
Jun 30, 2015 114.97%
Mar 31, 2015 -303.66%
Dec 31, 2014 118.34%
Sep 30, 2014 14.20%
Jun 30, 2014 -233.97%
Mar 31, 2014 14.29%
Dec 31, 2013 38.72%